Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group

Transplant Proc. 1998 Jun;30(4):1355-8. doi: 10.1016/s0041-1345(98)00274-7.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • African Continental Ancestry Group*
  • Bias
  • Cadaver
  • Cross-Over Studies
  • Cyclosporine / therapeutic use*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / epidemiology
  • Drug Therapy, Combination
  • European Continental Ancestry Group*
  • Follow-Up Studies
  • Graft Survival
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Immunosuppression / methods
  • Immunosuppressive Agents / therapeutic use*
  • Insulin / therapeutic use
  • Kidney Transplantation / immunology
  • Kidney Transplantation / mortality
  • Kidney Transplantation / physiology*
  • Postoperative Complications / epidemiology
  • Survival Rate
  • Tacrolimus / therapeutic use*
  • Time Factors
  • Tissue Donors
  • United States

Substances

  • Hypoglycemic Agents
  • Immunosuppressive Agents
  • Insulin
  • Cyclosporine
  • Tacrolimus